Th2-like cytokine activity in dermatitis herpetiformis

British Journal of Dermatology

Volumn 138, Issue 2, 1998, Pages 242-247

  Caproni, M ^a   Feliciani, C ^b   Fuligni, A ^a   Salvatore, E ^a   Atani, L ^a   Bianchi, B ^a   Mohammad Pour, S ^b   Proietto, G ^b   Toto, P ^b   Coscione, G ^b   Amerio, P ^b   Fabbri, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8;

ADOLESCENT; ADULT; ARTICLE; BULLOUS SKIN DISEASE; CELL INFILTRATION; CLINICAL ARTICLE; DERMATITIS HERPETIFORMIS; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CYTOKINES; DERMATITIS HERPETIFORMIS; EOSINOPHILS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SKIN; TH2 CELLS;

EID: 6844255862     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02068.x     Document Type: Article

References (35)

1. Fry L, Seah PP. Dermatitis herpetiformis: an evaluation of diagnostic criteria. Br J Dermatol 1974; 90: 137-46.
2. Hall RP. The pathogenesis of dermatitis herpetiformis: recent advances. J Am Acad Dermatol 1987; 16: 1129-44.
3. Garioch JJ, Unsworth DJ, Baker BS et al. Failure of intradermal skin testing with gluten to produce delayed hypersensitivity reactions in patients with dermatitis herpetiformis. Br J Dermatol 1995; 132: 698-702.
4. Baker BS, Garioch JJ, Bokth S et al. Lack of proliferative response by gluten-specific T cells in the blood and gut of patients with dermatitis herpetiformis. J Autoimmun 1995; 8: 561-74.
5. Garioch JJ, Baker BS, Leonard JN, Fry L. T lymphocytes in lesional skin of patients with dermatitis herpetiformis. Br J Dermatol 1994; 131: 822-6.
6. Romagnani S. Induction of Th1 and Th2 response: a key role for the natural immune response? Immunol Today 1992; 13: 379-81.
7. Resnick MB, Weller PF. Mechanism of eosinophil recruitment. Am J Respir Cell Mol Biol 1993; 8: 349-55.
8. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991; 77: 1859-70.
9. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-4.
10. Czek W, Krutmann J, Budnik A et al. Induction of intercellar adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. J Invest Dermatol 1993; 100: 417-23.
11. Schleimer RP, Sterbinski SA, Kaiser J et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992; 148: 1086-92.
12. Bousquet J, Chanez P, Lacoste JY et al. Eosinopbilic inflammation in asthma. N Engl J Med 1990; 323: 1033-9.
13. Caproni M, Bianchi B, D'Elios M et al. In vivo relevance CD30 in atopic dermatitis. Allergy, in press.
14. Caproni M, Palleschi GM, Falcos D et al. Serum eosinophil cationic protein (ECP) in bullous pemphigoid. Int J Dermatol 1995; 34: 177-80.
15. Fujisawa T, Abu Ghazaleh R, Kita H et al. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990; 44: 642-6.
16. Kita H, Weiler DA, Abu Ghazaleh R et al. Release of granule proteins from eosinophils cultured with IL-5. J Immunol 1992; 149: 629-35.
17. Graeber M, Baker BS, Garioch JJ et al. The role of cytokines in the generation of skin lesions in dermatitis herpetiformis. Br J Dermatol 1993; 129: 530-2.
18. Caproni M, Salvatore E, Fabbri P. Serum eosinophil cationic protein (ECP) and myeloperoxidase (MPO) levels in dermatitis herpetiformis: correlation with immunopathological, immunohistocheinical and clinical data. J Invest Dermatol 1995; 105: 518 (Abstr.).
19. Tanaka Y, Delaporte E, Dubucquoi S et al. Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J Invest Dermatol 1994; 103: 589-92.
20. Desreumaux P, Janin A, Delaporte E et al. Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis. Gut 1995; 37: 132-5.
21. Del Prete G, De Carli M, Almerigogna F et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995; 9: 81-6.
22. Uyemura K, Yamamura M, Fivenson DF et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type I cell-mediated response. J Invest Dermatol 1993; 101: 701-5.
23. Fabbri P. Dermatite erpetiforme. In: Immunodermatologia. Brescia: ISED. 1993; 266-72.
24. Smith EP, Zone JJ. Dermatitis herpetiformis and linear IgA bullous dermatosis. Dermatol Clin 1993; 11: 511-26.
25. Hall RP. Dermatitis herpetiformis. J Invest Dermatol 1992; 99: 871-3.
26. Yaoita H. Identification of IgA bindings structures in skin of patients with dermatitis herpetiformis. J Invest Dermatol 1978; 71: 213-6.
27. Lightner VA, Sakai LY, Hall RP. IgA-binding structures in dermatitis herpetiformis skin are independent of elastic-microfibrillar bundles. J Invest Dermatol 1991; 96: 88-92.
28. Dahlback K, Sakai L. IgA immunoreactive deposits colocal with fibrillin immunoreactive fibers in dermatitis herpetiformis. Acta Derm Venereol (Stockh) 1990; 70: 194-8.
29. Fry L. Dermatitis herpetiformis. Baillière's Clin Gastroenterol 1995; 9: 371-93.
30. Caligaris-Cappio F, Bertero MT, Converso M et al. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol 1995; 13: 339-43.
31. Pizzalo G, Vinante F, Morosato L et al. High serum level of soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994; 8: 741-5.
32. Venge P. Immunopharmacology of Eosinophils. Human Eosinophil Granule Proteins: Structure, Function and Release. London: Academic Press, 1993: 43-55.
33. Kristin M, Leiferman KM. A current perspective on the role of eosinophils in dermatologie disease. J Am Acad Dermatol 1991; 24: 1101.
34. Caproni M, Garofalo A, Palleschi GM et al. Deposition of eosinophil cationic protein (ECP) in perilesional skin of autoimmune bullous diseases. In: Third Congress EADV Copenhagen, Denmark, September 26-30, 1993; 56 (Abstr.).
35. Dubucquoi S, Desreumaux P, Janin A et al. Interleukin-5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 1994; 179: 703-8.